Skip to main content
    N

    Neuroone Medical Technologies Corp (NMTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.74
    -0.00 (-0.01%)

    Market Cap: $6.78M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Neuroone Medical Technologies Corp (NMTC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Neuroone Medical Technologies (NMTC) to earn -$0.63 per share in the fiscal year ending Sep 30, 2027, on revenue of $12.83M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Sep 30, 2027 were revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy133.3%
    Buy266.7%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    3

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year ending Sep 30, 2027
    -$0.63
    EPS consensus, revenue $12.83M
    Next report
    Dec 15, 2026
    Confirmed, after the close
    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Sep 30, 2027-$0.63-$0.78 to -$0.413$12.83M$11.00M to $14.49M3

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.17-$0.22 to -$0.143$3.07M$3.05M to $3.10M2

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 5 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Sep 30, 202703
    Quarter ending Dec 31, 202602

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has worsened from -$0.51.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Sep 30, 2027-$0.63-$0.63-$0.63-$0.51-$0.51N/A
    Quarter ending Dec 31, 2026-$0.17-$0.17-$0.17-$0.15-$0.15N/A

    Frequently Asked Questions About NMTC

    What is the NMTC stock forecast?

    Consensus analyst estimates put Neuroone Medical Technologies's EPS at -$0.63 for the fiscal year ending Sep 30, 2027, on revenue of $12.83M. The consensus rating from 3 analysts is Buy.

    How do analysts rate NMTC stock?

    Of 3 analysts covering Neuroone Medical Technologies, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from NMTC next year?

    For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is -$0.63, with estimates from -$0.78 to -$0.41 from 3 analysts.

    What revenue do analysts expect from Neuroone Medical Technologies next year?

    For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $12.83M, with estimates from $11.00M to $14.49M.

    How many analysts cover NMTC?

    3 analysts rate Neuroone Medical Technologies stock, and 3 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.